ABDOMEN THERMOGENICS
Food supplement declared in France, declaration No 2021-11-308, decision dated 6 November 2021
ABDOMEN THERMOGENICS (J.ARMOR) is a food supplement declared in France. Status: déclaré en France, commercialisation possible : l'administration ne s'est pas opposée à la déclaration (ce n'est ni une autorisation ni une évaluation de sécurité). 2 points in its composition require a check (prohibited substance, dose or novel food).
- Brand
- J.ARMOR
- Food business operator placing the product on the market
- ACME SRLS
- Status
- Déclaré en France, commercialisation possible : l'administration ne s'est pas opposée à la déclaration (ce n'est ni une autorisation ni une évaluation de sécurité)
- Form
- Capsule
- Daily dose
- 2 CAPSULES
- Intended populations
- Homme, Femme
- Not recommended for (according to the manufacturer)
- Adolescents (moins de 18 ans), Femmes allaitantes, Enfants (moins de 12 ans), Femmes enceintes, Utilisation prolongée, Enfants (de moins de 6 ans)
Declaration 312818, procedure Article 15. Compl'Alim, food supplement declarations (France), retrieved 23 October 2026.
Regulatory points
- Substance interdite
Contains the plant Garcinia cambogia (Garcinia gummi-gutta). In France, importing and placing food supplements containing it on the market are suspended until 17 April 2027 (arrêté du 16 avril 2026).
Source: French orders suspending food supplements containing a plant (Official Journal), checked against the text, arrêté du 16 avril 2026 (JORFTEXT000053907152).
- À vérifier
A product with the same brand and name was officially recalled in France (notice 2025-05-0067, published on 9 May 2025, lots 25 0576): publication de l'arrêté du 15 avril 2025 portant sur suspension de mise sur le marché en france de compléments alimentaires contenant la plante garcinia cambogia et le rappel des produits concernés. Check your product’s batch: a recall often targets specific batches.
Source: RappelConso, French official product recalls (DGCCRF): dietary foods and food supplements, fiche 2025-05-0067.
Declared composition
Plants
| Plant | Part | Preparation | Per day |
|---|---|---|---|
| Garcinia gummi-gutta (L.) Roxb. | Gomme résine | Autre extrait sec | 600 mg |
| Paullinia cupana Kunth | Fruit | Autre extrait sec | 200 mg |
| Piper nigrum L. | Graine | Autre extrait sec | 8 mg |
Other active ingredients
| Name | Per day |
|---|---|
| Acétylcarnitine | not declared |
| Acide lipoïque | not declared |
Additives
E470b, E464
List from the declaration, administrative decision dated (Compl'Alim, food supplement declarations (France)).
Label warnings
L'Acide lipoïque n'est pas recommandé aux patients ou aux personnes souffrant de diabète et de femmes enceintes et d'allaitement.Contient 20 mg de caféine par dose journalière recommandée,Il est recommandé de ne pas dépasser la dose quotidienne de 400 mg de toutes les sources de caféine. Ne pas utiliser pendant la grossesse et chez l'enfant, ni en aucun cas pendant des périodes prolongées sans consulter un médecin. Le produit n'est pas destiné à se substituer à une alimentation variée et doit être utilisé dans le cadre d'un mode de vie sain et actif. Ne pas dépasser la dose journalière recommandée, tenir à l'écart des enfants de moins de 3 ans. Bien refermer le récipient après utilisation. Il peut contenir des traces de protéines de lait, de soja, d'œuf et de gluten.Stockage : Il est recommandé d'éviter l'exposition aux sources de chaleur et aux changements brusques de température, de le stocker à l'abri de la lumière directe.
This information reproduces the manufacturer's declaration to the administration (DGAL). It does not say whether the product is effective and does not replace advice from a doctor or pharmacist, particularly during pregnancy or when taking medication.
Official warnings (Health Canada)
Health Canada publishes warnings on these ingredients:
- Garcinia gummi-gutta (L.) Roxb.
Read the warning, when it applies and the studies cited
MALABAR TAMARIND - GARCINIA GUMMI-GUTTA
Route of administration: Oral
Cautions and warnings
Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you are breastfeeding.
Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you have a liver disorder (HC 2025).
1 study cited in the text has no matching reference in the monograph (see the anomalies listed on the sources page).
Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you are taking medications (HC 2025).
1 study cited in the text has no matching reference in the monograph (see the anomalies listed on the sources page).
Stop use and ask a health care practitioner/health care provider/health care professional/doctor/physician if you experience any new symptoms including yellowing of the eyes or skin, dark urine, nausea, vomiting, stomach pain (HC 2025).
1 study cited in the text has no matching reference in the monograph (see the anomalies listed on the sources page).
Contraindications
Condition of application: All products.
Do not use if you are pregnant (HC 2010).
1 study cited in the text has no matching reference in the monograph (see the anomalies listed on the sources page).
- Acide lipoïque
Read the warning, when it applies and the studies cited
DL-ALPHA-LIPOIC ACID/R-ALPHA-LIPOIC ACID
Route of administration: Oral
Cautions and warnings
Condition of application: All products.
Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you are pregnant or breastfeeding.
Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you have diabetes (Jacob et al. 1999, Konrad et al. 1999, Packer et al. 1995).
3 studies cited in the text have no matching reference in the monograph (see the anomalies listed on the sources page).
Applies to products providing 42 milligrams or more DL-alpha-lipoic acid or 21 milligrams or more R-alpha-lipoic acid, per day.
Stop use and ask a health care practitioner/health care provider/health care professional/doctor/physician if you experience sweating, paleness, chills, headache, dizziness and/or confusion (as these may be symptoms of serious low blood sugar) (Bae et al., 2013; Gullo et al., 2014; Bresciani et al., 2011; Chang et al., 2009).
4 studies cited in the text have no matching reference in the monograph (see the anomalies listed on the sources page).
They concern the ingredient, not this product or its dose. They do not replace medical advice.
Brand : J.ARMOR
Is something on this product wrong or out of date, whether you are a reader or the brand? Write to contact@compoatlas.com: every correction is published in the corrections log.